FASTHEADLINENEWS

$AMGN Headlines

12 trading headlines for $AMGN

Apr 3 08:19 PM

If You Invested $100 In Amgen Stock 15 Years Ago, You Would Have This Much Today

generalAlpaca

Apr 3 04:37 PM

Amgen Expands Thyroid Eye Disease Bet With New AMG 732 Rollover Study

generalAlphaVantage

Apr 2 04:35 PM

Turning Up the Volume on IgG4-RD Awareness and Diagnosis

generalAlphaVantage

Apr 2 08:44 AM

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

fdaAlpaca

Apr 1 11:35 AM

Zai Lab and Amgen Team Up to Test New Combo Treatment for Lung Cancer

generalAlpaca

Mar 31 06:05 PM

FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos Use

fdaAlpaca

Mar 31 02:51 PM

FDA Adverse Event Monitoring System Q4 2025 Flags Multiple Potential New Drug Safety Signals, Including Hypersensitivity, Hypogammaglobulinemia, Colitis, Aplastic Anemia And Rhabdomyolysis Under Evaluation

earningsAlpaca

Mar 31 02:07 PM

FDA Identifies Cases Of Serious Liver Injury In Patients Taking Amgen's Tavneos For Severe Active Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis

fdaAlpaca

Mar 30 06:24 AM

Reported Saturday, Amgen's Repatha Reduces 3-P MACE Risk By 31% In VESALIUS-CV Subgroup Analysis Of 3,655 High-Risk Diabetic Patients Without Prior Heart Attack Or Stroke

generalAlpaca

Mar 29 05:18 PM

Assessing Regeneron Pharmaceuticals (REGN) Valuation After Japan’s New Dupixent Approval

fdaAlphaVantage

Mar 25 11:01 AM

Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from $375

analystYahoo Finance

Mar 23 05:13 PM

Gilead nearing up to $2 billion buyout of biotech Ouro Medicines, FT reports By Reuters

maAlphaVantage